Myagmar Bat-Erdene, Flynn James M, Cowley Patrick M, Swigart Philip M, Montgomery Megan D, Thai Kevin, Nair Divya, Gupta Rumita, Deng David X, Hosoda Chihiro, Melov Simon, Baker Anthony J, Simpson Paul C
From the Department of Medicine, VA Medical Center, San Francisco, CA (B.-E.M., P.M.C., P.M.S., M.D.M., K.T., D.N., R.G., D.X.D., C.H., A.J.B., P.C.S.); Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco (B.-E.M., P.M.C., M.D.M., D.X.D., C.H., A.J.B., P.C.S.); and Buck Institute for Research on Aging, Novato, CA (J.M.F., S.M.).
Circ Res. 2017 Mar 31;120(7):1103-1115. doi: 10.1161/CIRCRESAHA.117.310520. Epub 2017 Feb 20.
It is unknown whether every ventricular myocyte expresses all 5 of the cardiac adrenergic receptors (ARs), β1, β2, β3, α1A, and α1B. The β1 and β2 are thought to be the dominant myocyte ARs.
Quantify the 5 cardiac ARs in individual ventricular myocytes.
We studied ventricular myocytes from wild-type mice, mice with α1A and α1B knockin reporters, and β1 and β2 knockout mice. Using individual isolated cells, we measured knockin reporters, mRNAs, signaling (phosphorylation of extracellular signal-regulated kinase and phospholamban), and contraction. We found that the β1 and α1B were present in all myocytes. The α1A was present in 60%, with high levels in 20%. The β2 and β3 were detected in only ≈5% of myocytes, mostly in different cells. In intact heart, 30% of total β-ARs were β2 and 20% were β3, both mainly in nonmyocytes.
The dominant ventricular myocyte ARs present in all cells are the β1 and α1B. The β2 and β3 are mostly absent in myocytes but are abundant in nonmyocytes. The α1A is in just over half of cells, but only 20% have high levels. Four distinct myocyte AR phenotypes are defined: 30% of cells with β1 and α1B only; 60% that also have the α1A; and 5% each that also have the β2 or β3. The results raise cautions in experimental design, such as receptor overexpression in myocytes that do not express the AR normally. The data suggest new paradigms in cardiac adrenergic signaling mechanisms.
尚不清楚每个心室肌细胞是否都表达心脏肾上腺素能受体(ARs)的全部5种类型,即β1、β2、β3、α1A和α1B。β1和β2被认为是主要的心肌细胞ARs。
对单个心室肌细胞中的5种心脏ARs进行定量分析。
我们研究了野生型小鼠、携带α1A和α1B敲入报告基因的小鼠以及β1和β2基因敲除小鼠的心室肌细胞。使用单个分离细胞,我们测量了敲入报告基因、mRNA、信号传导(细胞外信号调节激酶和受磷蛋白的磷酸化)以及收缩情况。我们发现β1和α1B存在于所有肌细胞中。α1A存在于60%的肌细胞中,其中20%含量较高。β2和β3仅在约5%的肌细胞中被检测到,且大多存在于不同细胞中。在完整心脏中,总β-ARs的30%为β2,20%为β3,两者主要存在于非心肌细胞中。
所有细胞中存在的主要心室肌细胞ARs是β1和α1B。β2和β3在心肌细胞中大多不存在,但在非心肌细胞中含量丰富。α1A存在于略超过一半的细胞中,但只有20%含量较高。定义了四种不同的心肌细胞AR表型:30%的细胞仅含β1和α1B;60%的细胞还含有α1A;各有5%的细胞还含有β2或β3。这些结果对实验设计提出了警示,例如在正常不表达AR的心肌细胞中进行受体过表达。这些数据提示了心脏肾上腺素能信号传导机制的新范式。